CAS Number673-31-4
SynonymsQuamaquil; Extacol; Proformiphen; Carbamic Acid 3-Phenylpropyl Ester; phenprobamate; Nelaxan; 3-Phenylpropyl carbamate; Gamaquil; EINECS 211-606-1; MFCD00868163; Eirenal; benzenepropanol; g-Phenylpropyl Carbamate; 3-Phenylpropyl hydrogen carbonimidate; Palmita; Ansepron; Benzenepropanol, carbamate; Actiphan; Actozine
Molecular FormulaC10H13O2N1
Molecular Weight179.22
Purity98.00%
Density1.1±0.1 g/cm3
Boiling Point295.5±33.0 °C at 760 mmHg
Melting Point101-104℃
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 673-31-4 |
| Catalog No. | 2A-9024820 |
| Chinese Name | 苯丙氨酯 |
| Synonyms | Quamaquil; Extacol; Proformiphen; Carbamic Acid 3-Phenylpropyl Ester; phenprobamate; Nelaxan; 3-Phenylpropyl carbamate; Gamaquil; EINECS 211-606-1; MFCD00868163; Eirenal; benzenepropanol; g-Phenylpropyl Carbamate; 3-Phenylpropyl hydrogen carbonimidate; Palmita; Ansepron; Benzenepropanol, carbamate; Actiphan; Actozine |
| Molecular Formula | C10H13O2N1 |
| Molecular Weight | 179.22 |
| Purity | 98.00 |
| Density | 1.1±0.1 g/cm3 |
| Boiling Point | 295.5±33.0 °C at 760 mmHg |
| Melting Point | 101-104℃ |
| Storage Condition | room temperature |
| Application | Phenylalabamate (3-phenylpropylcarbamate; MH 532; profomifene) is a widely used centrally acting skeletal muscle relaxant with sedative and anticonvulsant effects [1]. |
| HTC | 2924299090 |
| MDL Number | MFCD00868163 |
| SMILES | NC(=O)OCCCc1ccccc1 |
| InChI | InChI=1S/C10H13NO2/c11-10(12)13-8-4-7-9-5-2-1-3-6-9/h1-3,5-6H,4,7-8H2,(H2,11,12) |
| InChI Key | CAMYKONBWHRPDD-UHFFFAOYSA-N |
| MSDS | msds/24820_1_673_31_4.pdf |
| Use of | Phenprobamate (3-Phenylpropyl carbamate; MH 532; Proformiphen) is a widely used, centrally acting skeletal muscle relaxant, with sedative and anticonvulsant effects[1]. Properties Name 3-phenylpropyl carbamate Synonym More Synonyms phenprobamate Biological Activity Description Phenprobamate (3-Phenylpropyl carbamate; MH 532; Proformiphen) is a widely used, centrally acting skeletal muscle relaxant, with sedative and anticonvulsant effects[1]. Related Catalog Signaling Pathways >> Others >> Others Research Areas >> Neurological Disease References [1]. J X Sun, et al. High-performance liquid chromatographic analysis, plasma protein binding and red blood cell partitioning of phenprobamate. Biopharm Drug Dispos. Jul-Aug 1987;8(4):341-51. Chemical & Physical Properties Molecular Formula C10H13NO2 Exact Mass 179.094635 PSA 52.32000 Index of Refraction 1.519 InChIKey CAMYKONBWHRPDD-UHFFFAOYSA-N Toxicological Information CHEMICAL IDENTIFICATION RTECS NUMBER : CHEMICAL NAME : 1-Propanol, 3-phenyl-, carbamate CAS REGISTRY NUMBER : LAST UPDATED : DATA ITEMS CITED : MOLECULAR FORMULA : C10-H13-N-O2 MOLECULAR WEIGHT : WISWESSER LINE NOTATION : HEALTH HAZARD DATA ACUTE TOXICITY DATA TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : SPECIES OBSERVED : Rodent - rat DOSE/DURATION : TOXIC EFFECTS : Behavioral - altered sleep time (including change in righting reflex) REFERENCE : ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 13,856,1963 TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intraperitoneal SPECIES OBSERVED : Rodent - rat DOSE/DURATION : TOXIC EFFECTS : Biochemical - Metabolism (Intermediary) - effect on inflammation or mediation of inflammation REFERENCE : AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- Volume(issue)/page/year: 123,140,1959 TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : TOXIC EFFECTS : Behavioral - altered sleep time (including change in righting reflex) Behavioral - convulsions or effect on seizure threshold REFERENCE : ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 12,340,1962 TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intraperitoneal SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : NTIS** National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific & Technical Information. Volume(issue)/page/year: AD691-490 TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : MEIEDD Merck Index. (Merck & Co., Inc., Rahway, NJ 07065) 10th ed. 1983. For publisher information, see 85KYAH. Volume(issue)/page/year: 10,1047,1983 TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : SPECIES OBSERVED : Rodent - rabbit DOSE/DURATION : TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : 27ZQAG "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972 Volume(issue)/page/year: -,402,1972 TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intraperitoneal SPECIES OBSERVED : Rodent - rabbit DOSE/DURATION : TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : 27ZQAG "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972 Volume(issue)/page/year: -,402,1972 TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : SPECIES OBSERVED : Rodent - guinea pig DOSE/DURATION : TOXIC EFFECTS : Behavioral - somnolence (general depressed activity) Behavioral - tremor REFERENCE : ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 9,143,1959 TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intraperitoneal SPECIES OBSERVED : Rodent - guinea pig DOSE/DURATION : TOXIC EFFECTS : Behavioral - somnolence (general depressed activity) Behavioral - tremor REFERENCE : ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 9,143,1959 Safety Information HS Code 2924299090 Synthetic Route Total: 1 Page 3-Phenylpropan-1-ol CAS#:122-97-4 Phenyl carbamate CAS#:622-46-8 phenprobamate CAS#:673-31-4 Literature: Ichikawa, Yoshiyasu; Morishita, Yukinori; Kusaba, Shuhei; Sakiyama, Naoto; Matsuda, Yasunori; Nakano, Keiji; Kotsuki, Hiyoshizo Synlett, 2010 , # 12 p. 1815 - 1818 3-Phenylpropan-1-ol CAS#:122-97-4 phenprobamate CAS#:673-31-4 Literature: European Journal of Organic Chemistry, , # 5 p. 908 - 911 3-Phenylpropan-1-ol CAS#:122-97-4 Sodium cyanide CAS#:143-33-9 phenprobamate CAS#:673-31-4 Literature: Chemical and Pharmaceutical Bulletin, , vol. 33, # 6 p. 2403 - 2410 Precursor & DownStream Precursor 3 CAS#:122-97-4 3-Phenylpropan-1-ol CAS#:622-46-8 Phenyl carbamate CAS#:143-33-9 Sodium cyanide DownStream 0 |
| Tax Rebate | 13.0% |
| Supervision | None. MFN tariff: 6.5%. Ordinary tariff: 30.0% |
| Transport Info | Product name: Summary 2924299090. other cyclic amides (including cyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
| Related Products in Specialty Chemicals | ||
|---|---|---|
| N-Morpholino-1-cyclohexene | 670-80-4 | 2A-9024801 |
| 4-Chloro-3-iodobenzotrifluoride | 672-57-1 | 2A-9024811 |
| (1-Chloroethyl)benzene | 672-65-1 | 2A-9024813 |
| L-alpha-Methyltyrosine | 672-87-7 | 2A-9024816 |
| 4-Methoxy-6-methylpyran-2-one | 672-89-9 | 2A-9024817 |
| 1-Aza-2-cyclooctanone | 673-66-5 | 2A-9024821 |
| DL-Mevalonolactone | 674-26-0 | 2A-9024822 |
| 4,6-Dimethyl-2-pyrone | 675-09-2 | 2A-9024825 |
| 2-(3,5-DIMETHYL-ISOXAZOL-4-YL)-ETHYLAMINE | 510717-69-8 | 2A-9024828 |
| 2-Piperidone | 675-20-7 | 2A-9024829 |
| Browse all Specialty Chemicals products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA
EN
SDS